Home Cart Sign in  
Chemical Structure| 499-44-5 Chemical Structure| 499-44-5

Structure of Hinokitiol
CAS No.: 499-44-5

Chemical Structure| 499-44-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hinokitiol, an iron chelator originally extracted from woods of Thuja plicata and Chamaecyparis obtuse, has been found to inhibit ultraviolet B-induced apoptosis in keratinocytes of murine ear skin via antioxidant activity of metallothionein. It can partially mimic the function of missing protein transporters of iron, and possibly other ions, may have potential in treating human diseases.

Synonyms: β-Thujaplicin; NSC 18804; 4-Isopropyltropolone

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Hinokitiol

CAS No. :499-44-5
Formula : C10H12O2
M.W : 164.20
SMILES Code : O=C1C(O)=CC(C(C)C)=CC=C1
Synonyms :
β-Thujaplicin; NSC 18804; 4-Isopropyltropolone
MDL No. :MFCD00040180
InChI Key :FUWUEFKEXZQKKA-UHFFFAOYSA-N
Pubchem ID :3611

Safety of Hinokitiol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312+P330-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
normal liver cell line HL-7702 25, 50, 100, 200, 400 nM 24, 48, 72 h To evaluate the effect of β-Thujaplicin on normal liver cells, results showed that β-Thujaplicin had only a slight effect on the viability of HL-7702 cells at 400 nM PMC6420571
human hepatoma cell lines HCCLM3 25, 50, 100, 200, 400 nM 24, 48, 72 h To evaluate the inhibitory effect of β-Thujaplicin on HCC cell growth, results showed that β-Thujaplicin significantly inhibited the viability of HCCLM3 cells in a dose-dependent manner PMC6420571
human hepatoma cell lines SMMC-7721 25, 50, 100, 200, 400 nM 24, 48, 72 h To evaluate the inhibitory effect of β-Thujaplicin on HCC cell growth, results showed that β-Thujaplicin significantly inhibited the viability of SMMC-7721 cells in a dose-dependent manner PMC6420571
human hepatoma cell lines HepG2 25, 50, 100, 200, 400 nM 24, 48, 72 h To evaluate the inhibitory effect of β-Thujaplicin on HCC cell growth, results showed that β-Thujaplicin significantly inhibited the viability of HepG2, SMMC-7721, and HCCLM3 cells in a dose-dependent manner PMC6420571

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice HepG2 tumor xenograft model Intraperitoneal injection 5 mg/kg body weight Once daily for 15 days To verify the antitumor effect of β-Thujaplicin in vivo, results showed that β-Thujaplicin significantly inhibited the growth of HepG2 tumor xenografts PMC6420571

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.09mL

1.22mL

0.61mL

30.45mL

6.09mL

3.05mL

60.90mL

12.18mL

6.09mL

References

 

Historical Records

Categories